Business Description
Kiora Pharmaceuticals Inc
NAICS : 325413
SIC : 2835
ISIN : US30233M1071
Description
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 339.24 | |||||
Equity-to-Asset | 0.81 | |||||
Debt-to-EBITDA | 0.03 | |||||
Interest Coverage | 524.33 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | -2.27 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 64.7 | |||||
3-Year EPS without NRI Growth Rate | 68.9 | |||||
3-Year FCF Growth Rate | 68.4 | |||||
3-Year Book Growth Rate | -77.5 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
9-Day RSI | 11.48 | |||||
14-Day RSI | 16.05 | |||||
6-1 Month Momentum % | -89.02 | |||||
12-1 Month Momentum % | -90.74 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 19.22 | |||||
Quick Ratio | 19.22 | |||||
Cash Ratio | 16.8 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -281.4 | |||||
Shareholder Yield % | -131.07 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | 39.33 | |||||
Net Margin % | 19.99 | |||||
FCF Margin % | 29.47 | |||||
ROE % | 16.69 | |||||
ROA % | 12.05 | |||||
ROIC % | 61.31 | |||||
3-Year ROIIC % | 12.59 | |||||
ROC (Joel Greenblatt) % | 2471.15 | |||||
ROCE % | 10.37 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Forward PE Ratio | 0.34 | |||||
Price-to-Owner-Earnings | 6.13 | |||||
PS Ratio | 0.89 | |||||
PB Ratio | 0.33 | |||||
Price-to-Tangible-Book | 0.44 | |||||
EV-to-EBIT | -6.58 | |||||
EV-to-EBITDA | -6.51 | |||||
EV-to-Revenue | -1.06 | |||||
EV-to-Forward-Revenue | 0.66 | |||||
EV-to-FCF | -3.53 | |||||
Price-to-Net-Current-Asset-Value | 0.45 | |||||
Price-to-Net-Cash | 0.54 | |||||
Earnings Yield (Greenblatt) % | -15.2 | |||||
FCF Yield % | 44.3 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Kiora Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 14.72 | ||
EPS (TTM) (€) | -11.22 | ||
Beta | 0.62 | ||
Volatility % | 96.64 | ||
14-Day RSI | 16.05 | ||
14-Day ATR (€) | 0.000266 | ||
20-Day SMA (€) | 0.4208 | ||
12-1 Month Momentum % | -90.74 | ||
52-Week Range (€) | 0.4208 - 8.163 | ||
Shares Outstanding (Mil) | 2.97 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Kiora Pharmaceuticals Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Kiora Pharmaceuticals Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Kiora Pharmaceuticals Inc Frequently Asked Questions
What is Kiora Pharmaceuticals Inc(FRA:7EY)'s stock price today?
When is next earnings date of Kiora Pharmaceuticals Inc(FRA:7EY)?
Does Kiora Pharmaceuticals Inc(FRA:7EY) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |